Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -159.9% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 5.7 | n/a |
Pr/Book | 4.2 |
Latest | F'cast | |
---|---|---|
Revenue | 4512.8% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-20 | 0.09 | (1.85) | (1.27)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-24 | 0.08 | (4.26) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-25 | 1.91 | (3.34) | (0.96)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Annual Financial Report to 31 March 2024 | 23-Jun-2025 | 07:00 | RNS |
Update on the publication of financial results | 30-May-2025 | 07:00 | RNS |
£1m raised from issuance of convertible loa... | 23-May-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 2.15p |
Closing Price Change | 0.000p |
% Change | 0.00 % |
52 Week High | 2.40 |
52 Week Low | 2.10 |
Volume | 0 |
Shares Issued | 506.29m |
Market Cap | £10.89m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research